Standout Papers

Osteoclast differentiation and activation 1998 2026 2007 2016 5.1k
  1. Osteoclast differentiation and activation (2003)
    William J. Boyle, W. Scott Simonet et al. Nature
  2. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis (1999)
    Young‐Yun Kong, Hiroki Yoshida et al. Nature
  3. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification (1998)
    Nathan Bucay, Ildiko Sarosi et al. Genes & Development
  4. The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption (2000)
    Lorenz C. Hofbauer, Sundeep Khosla et al. Journal of Bone and Mineral Research
  5. Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival (2010)
    Xiaolan Zhou, John Lu et al. Cell
  6. Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis (2008)
    Xiaodong Li, Michael S. Ominsky et al. Journal of Bone and Mineral Research
  7. The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development (2000)
    Jimmie E. Fata, Young‐Yun Kong et al. Cell
  8. Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1 (1999)
    Lorenz C. Hofbauer, Francesca Gori et al. Endocrinology
  9. The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts (1999)
    Teresa L. Burgess, Yixin Qian et al. The Journal of Cell Biology
  10. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women (2003)
    Sundeep Khosla, Arunik Sanyal et al. Journal of Clinical Investigation
  11. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women (2003)
    Sundeep Khosla, Arunik Sanyal et al. Journal of Clinical Investigation
  12. Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells (1999)
    Lorenz C. Hofbauer, David L. Lacey et al. Bone
  13. Estrogen Stimulates Gene Expression and Protein Production of Osteoprotegerin in Human Osteoblastic Cells* (1999)
    Lorenz C. Hofbauer, Sundeep Khosla et al. Endocrinology

Immediate Impact

9 by Nobel laureates 35 from Science/Nature 76 standout
Sub-graph 1 of 18

Citing Papers

Physiology and diseases of tissue-resident macrophages
2023 StandoutNature
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
19 intermediate papers

Works of David L. Lacey being referenced

Osteoclast differentiation and activation
2003 StandoutNature
Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation
2002
and 11 more

Author Peers

Author Last Decade Papers Cites
David L. Lacey 15761 11110 5269 101 23.4k
Brendan F. Boyce 14257 10342 4859 197 24.4k
T. John Martin 13998 10230 3405 279 21.5k
Nobuyuki Udagawa 18264 12451 4530 228 25.6k
Stavros C. Manolagas 13868 8182 6478 138 22.5k
Tatsuo Suda 13261 8042 2891 205 21.1k
Roland Baron 14594 7353 3577 249 22.2k
Gregory R. Mundy 18475 18127 5961 330 36.6k
Gideon A. Rodan 14447 10693 6321 255 25.9k
F. Patrick Ross 10648 5855 2243 194 16.5k
T. John Martin 10220 9165 3107 260 17.6k

All Works

Loading papers...

Rankless by CCL
2026